Appleton Partners’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-8,677
| Closed | -$288K | – | 251 |
|
|
2017
Q2 | $288K | Sell |
8,677
-510
| -6% | -$16.9K | 0.05% | 204 |
|
|
2017
Q1 | $295K | Sell |
9,187
-200
| -2% | -$6.42K | 0.05% | 196 |
|
|
2016
Q4 | $340K | Sell |
9,387
-2,290
| -20% | -$82.9K | 0.07% | 168 |
|
|
2016
Q3 | $537K | Sell |
11,677
-150
| -1% | -$6.9K | 0.1% | 149 |
|
|
2016
Q2 | $594K | Sell |
11,827
-451
| -4% | -$22.7K | 0.12% | 136 |
|
|
2016
Q1 | $657K | Buy |
12,278
+4,890
| +66% | +$262K | 0.13% | 125 |
|
|
2015
Q4 | $485K | Buy |
7,388
+285
| +4% | +$18.7K | 0.1% | 148 |
|
|
2015
Q3 | $401K | Sell |
7,103
-1,501
| -17% | -$84.7K | 0.09% | 149 |
|
|
2015
Q2 | $508K | Buy |
8,604
+100
| +1% | +$5.9K | 0.11% | 125 |
|
|
2015
Q1 | $530K | Hold |
8,504
| – | – | 0.12% | 125 |
|
|
2014
Q4 | $489K | Sell |
8,504
-280
| -3% | -$16.1K | 0.11% | 119 |
|
|
2014
Q3 | $472K | Buy |
8,784
+1,176
| +15% | +$63.2K | 0.11% | 119 |
|
|
2014
Q2 | $399K | Hold |
7,608
| – | – | 0.09% | 130 |
|
|
2014
Q1 | $402K | Sell |
7,608
-440
| -5% | -$23.2K | 0.1% | 125 |
|
|
2013
Q4 | $323K | Sell |
8,048
-350
| -4% | -$14K | 0.08% | 130 |
|
|
2013
Q3 | $317K | Sell |
8,398
-520
| -6% | -$19.6K | 0.09% | 127 |
|
|
2013
Q2 | $350K | Buy |
+8,918
| New | +$350K | 0.1% | 107 |
|